530 related articles for article (PubMed ID: 16943728)
1. Severe pneumococcal pneumonia: new strategies for management.
Chiou CC; Yu VL
Curr Opin Crit Care; 2006 Oct; 12(5):470-6. PubMed ID: 16943728
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
Jover F; Cuadrado JM; Andreu L; Martínez S; Cañizares R; de la Tabla VO; Martin C; Roig P; Merino J
Eur J Intern Med; 2008 Jan; 19(1):15-21. PubMed ID: 18206596
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
Feldman C
J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
[TBL] [Abstract][Full Text] [Related]
4. A clinical solution to antimicrobial resistance in community-acquired pneumonia: narrowing the spectrum of antimicrobial therapy: comment on "Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy".
Yu VL
Arch Intern Med; 2011 Jan; 171(2):172-3. PubMed ID: 21263107
[No Abstract] [Full Text] [Related]
5. Streptococcus pneumoniae: does antimicrobial resistance matter?
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
[TBL] [Abstract][Full Text] [Related]
6. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia.
Metlay JP; Hofmann J; Cetron MS; Fine MJ; Farley MM; Whitney C; Breiman RF
Clin Infect Dis; 2000 Mar; 30(3):520-8. PubMed ID: 10722438
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance.
Moroney JF; Fiore AE; Harrison LH; Patterson JE; Farley MM; Jorgensen JH; Phelan M; Facklam RR; Cetron MS; Breiman RF; Kolczak M; Schuchat A
Clin Infect Dis; 2001 Sep; 33(6):797-805. PubMed ID: 11512085
[TBL] [Abstract][Full Text] [Related]
8. [Community acquired pneumococcal pneumonia in hospitalized adult patients].
Díaz A; Torres C; Flores LJ; García P; Saldías F
Rev Med Chil; 2003 May; 131(5):505-14. PubMed ID: 12879811
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance and treatment of community-acquired pneumonia.
Mandell LA
Clin Chest Med; 2005 Mar; 26(1):57-64. PubMed ID: 15802166
[TBL] [Abstract][Full Text] [Related]
10. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
Rothermel CD
Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368
[TBL] [Abstract][Full Text] [Related]
11. Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy.
Sordé R; Falcó V; Lowak M; Domingo E; Ferrer A; Burgos J; Puig M; Cabral E; Len O; Pahissa A
Arch Intern Med; 2011 Jan; 171(2):166-72. PubMed ID: 20876397
[TBL] [Abstract][Full Text] [Related]
12. [Contribution of urinary pneumococcal antigen detection combined with the research of legionella antigen for diagnosis of pneumonia in hospitalized patients].
Honoré S; Trillard M; Ould-Hocine Z; Lesprit P; Deforges L; Legrand P
Pathol Biol (Paris); 2004 Oct; 52(8):429-33. PubMed ID: 15465259
[TBL] [Abstract][Full Text] [Related]
13. [Assessment of the contribution of the immunochromatographic pneumococcal urinary antigen test to the etiological diagnosis of pneumonia in hospitalized adults].
Segonds C; Le Goff A; Chabanon G
Pathol Biol (Paris); 2010 Apr; 58(2):117-22. PubMed ID: 19875240
[TBL] [Abstract][Full Text] [Related]
14. Community-acquired bacteraemic pneumococcal pneumonia in adults: effect of diminished penicillin susceptibility on clinical outcome.
Bonnard P; Lescure FX; Douadi Y; Schmit JL; Jounieaux V; Laurans G; Eb F; Ducroix JP
J Infect; 2005 Jul; 51(1):69-76. PubMed ID: 15979494
[TBL] [Abstract][Full Text] [Related]
15. Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?
Peterson LR
Clin Infect Dis; 2006 Jan; 42(2):224-33. PubMed ID: 16355333
[TBL] [Abstract][Full Text] [Related]
16. Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy.
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2005 Dec; 26(6):575-616. PubMed ID: 16388429
[TBL] [Abstract][Full Text] [Related]
17. Management of nonsevere pneumonia in military trainees with the urinary antigen test for Streptococcus pneumoniae: an innovative approach to targeted therapy.
Guchev IA; Yu VL; Sinopalnikov A; Klochkov OI; Kozlov RS; Stratchounski LS
Clin Infect Dis; 2005 Jun; 40(11):1608-16. PubMed ID: 15889358
[TBL] [Abstract][Full Text] [Related]
18. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H
Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863
[No Abstract] [Full Text] [Related]
19. Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults.
Korsgaard J; Møller JK; Kilian M
Int J Infect Dis; 2005 Sep; 9(5):274-9. PubMed ID: 16095941
[TBL] [Abstract][Full Text] [Related]
20. Community-acquired pneumonia: new management strategies for evolving pathogens and antimicrobial susceptibilities.
Klugman KP; Low DE; Metlay J; Pechere JC; Weiss K
Int J Antimicrob Agents; 2004 Nov; 24(5):411-22. PubMed ID: 15519470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
